Pediatric Inflammatory Bowel Disease /
Pediatric Inflammatory Bowel Disease /
edited by Petar Mamula, Judith R. Kelsen, Andrew B. Grossman, Robert N. Baldassano, Jonathan E. Markowitz.
- 4th ed. 2023.
- XXIV, 861 páginas 150 ilustraciones , 100 ilustraciones in color. recurso en línea.
Etiology and Pathogenesis -- Genetics of Inflammatory Bowel Diseases -- Immunologic Regulation of Health and Inflammation in the Intestine -- Cytokines and Inflammatory Bowel Disease -- The Gut Microbiota and Inflammatory Bowel Disease -- Immune Dysregulation Associated with Very Early-Onset Inflammatory Bowel Disease -- Epidemiology and Clinical Features -- The Epidemiology of Pediatric Inflammatory Bowel Disease -- The Natural History of Crohn Disease in Children -- Natural History of Ulcerative Colitis in Children -- Pediatric Inflammatory Bowel Disease - Unclassified -- Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease -- Liver Disease in Pediatric Inflammatory Bowel Disease -- Growth Impairment in Pediatric Inflammatory Bowel Disease -- Inflammatory Bowel Diseases and Skeletal Health -- Puberty and Pediatric-Onset Inflammatory Bowel Disease -- Classification of Pediatric Inflammatory Bowel Disease -- Diagnosis -- The History andPhysical Exam -- Differential Diagnosis of Inflammatory Bowel Disease -- Laboratory Evaluation of Inflammatory Bowel Disease -- Fecal Markers in Inflammatory Bowel Disease -- Radiologic Evaluation of Pediatric Inflammatory Bowel Disease -- Endoscopy and Inflammatory Bowel Disease -- The Pathology of Chronic Inflammatory Bowel Disease -- Capsule Endoscopy in Pediatric Inflammatory Bowel Disease -- Bone Health in Pediatric Inflammatory Bowel Disease -- Medical Therapy -- 5-Aminosalicylate Therapy -- Antibiotic Therapy -- Nutritional Management of Inflammatory Bowel Disease -- Corticosteroid Therapy -- 6-Mercaptopurine Therapy -- Methotrexate -- Infliximab Therapy for Pediatric Crohn's Disease and Ulcerative Colitis -- Anti-TNF Therapies Other Than Infliximab for the Treatment of Pediatric Inflammatory Bowel Disease -- Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease -- New Non-anti-TNF-α Biological Therapies for the Treatment of Inflammatory Bowel Disease -- Medical Treatment of Perianal Crohn's Disease Fistulae Treatment of Perianal Crohn's Disease -- Treatment of Acute Severe Ulcerative Colitis -- Dietary Therapies for Inflammatory Bowel Disease -- Integrative Health Therapies for Pediatric IBD -- Surgical Therapy -- Management of Intraabdominal Complications of Inflammatory Bowel Disease -- Surgical Management of Crohn Disease in Children -- Surgical Treatment of Ulcerative Colitis -- Postoperative Surveillance and Management of Crohn's Disease -- Perioperative Immunosuppression in Inflammatory Bowel Disease -- Pouchitis and Pouch-Related Complications -- Title to come -- Research -- Clinical Indices for Pediatric Inflammatory Bowel Disease Research -- Clinical Trials (Clinical Perspective) -- Global Regulatory Industry Perspective of Clinical Trials -- Special Considerations -- Infectious Complications of Pediatric Inflammatory Bowel Disease -- Psychological Aspects of Inflammatory Bowel Disease in Children and Adolescents -- Measurement of Quality of Life in Pediatric Inflammatory Bowel Disease -- Irritable Bowel Syndrome and Functional GI Disorders in Inflammatory Bowel Disease -- Inflammatory Bowel Disease in Pregnancy -- Pediatric Inflammatory Bowel Disease Care in Low and Middle-Income Countries -- Immunizations in The Child with Inflammatory Bowel Disease -- Colitis-Associated Cancers -- Quality Improvement in Inflammatory Bowel Disease -- Fostering Self-Management and Patient Activation -- Advocacy for Pediatric Patients with Inflammatory Bowel Disease -- Advocacy for Pediatric Patients with Inflammatory Bowel Disease -- Transition from Pediatric to Adult Care.
9783031147449
10.1007/978-3-031-14744-9 doi
Internal medicine.
Pediatrics.
Internal Medicine.
Pediatrics.
616
Etiology and Pathogenesis -- Genetics of Inflammatory Bowel Diseases -- Immunologic Regulation of Health and Inflammation in the Intestine -- Cytokines and Inflammatory Bowel Disease -- The Gut Microbiota and Inflammatory Bowel Disease -- Immune Dysregulation Associated with Very Early-Onset Inflammatory Bowel Disease -- Epidemiology and Clinical Features -- The Epidemiology of Pediatric Inflammatory Bowel Disease -- The Natural History of Crohn Disease in Children -- Natural History of Ulcerative Colitis in Children -- Pediatric Inflammatory Bowel Disease - Unclassified -- Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease -- Liver Disease in Pediatric Inflammatory Bowel Disease -- Growth Impairment in Pediatric Inflammatory Bowel Disease -- Inflammatory Bowel Diseases and Skeletal Health -- Puberty and Pediatric-Onset Inflammatory Bowel Disease -- Classification of Pediatric Inflammatory Bowel Disease -- Diagnosis -- The History andPhysical Exam -- Differential Diagnosis of Inflammatory Bowel Disease -- Laboratory Evaluation of Inflammatory Bowel Disease -- Fecal Markers in Inflammatory Bowel Disease -- Radiologic Evaluation of Pediatric Inflammatory Bowel Disease -- Endoscopy and Inflammatory Bowel Disease -- The Pathology of Chronic Inflammatory Bowel Disease -- Capsule Endoscopy in Pediatric Inflammatory Bowel Disease -- Bone Health in Pediatric Inflammatory Bowel Disease -- Medical Therapy -- 5-Aminosalicylate Therapy -- Antibiotic Therapy -- Nutritional Management of Inflammatory Bowel Disease -- Corticosteroid Therapy -- 6-Mercaptopurine Therapy -- Methotrexate -- Infliximab Therapy for Pediatric Crohn's Disease and Ulcerative Colitis -- Anti-TNF Therapies Other Than Infliximab for the Treatment of Pediatric Inflammatory Bowel Disease -- Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease -- New Non-anti-TNF-α Biological Therapies for the Treatment of Inflammatory Bowel Disease -- Medical Treatment of Perianal Crohn's Disease Fistulae Treatment of Perianal Crohn's Disease -- Treatment of Acute Severe Ulcerative Colitis -- Dietary Therapies for Inflammatory Bowel Disease -- Integrative Health Therapies for Pediatric IBD -- Surgical Therapy -- Management of Intraabdominal Complications of Inflammatory Bowel Disease -- Surgical Management of Crohn Disease in Children -- Surgical Treatment of Ulcerative Colitis -- Postoperative Surveillance and Management of Crohn's Disease -- Perioperative Immunosuppression in Inflammatory Bowel Disease -- Pouchitis and Pouch-Related Complications -- Title to come -- Research -- Clinical Indices for Pediatric Inflammatory Bowel Disease Research -- Clinical Trials (Clinical Perspective) -- Global Regulatory Industry Perspective of Clinical Trials -- Special Considerations -- Infectious Complications of Pediatric Inflammatory Bowel Disease -- Psychological Aspects of Inflammatory Bowel Disease in Children and Adolescents -- Measurement of Quality of Life in Pediatric Inflammatory Bowel Disease -- Irritable Bowel Syndrome and Functional GI Disorders in Inflammatory Bowel Disease -- Inflammatory Bowel Disease in Pregnancy -- Pediatric Inflammatory Bowel Disease Care in Low and Middle-Income Countries -- Immunizations in The Child with Inflammatory Bowel Disease -- Colitis-Associated Cancers -- Quality Improvement in Inflammatory Bowel Disease -- Fostering Self-Management and Patient Activation -- Advocacy for Pediatric Patients with Inflammatory Bowel Disease -- Advocacy for Pediatric Patients with Inflammatory Bowel Disease -- Transition from Pediatric to Adult Care.
9783031147449
10.1007/978-3-031-14744-9 doi
Internal medicine.
Pediatrics.
Internal Medicine.
Pediatrics.
616